Targeting STING pathways for the treatment of cancer

Oncoimmunology. 2015 Jan 7;4(12):e988463. doi: 10.4161/2162402X.2014.988463. eCollection 2015 Dec.

Abstract

Recently, we demonstrated that stimulator of interferon genes (STING) ligand cyclic di-guanylate (c-di-GMP) is an excellent adjuvant in cancer vaccination but also induces immunogenic tumor cell death. Combination of both pathways resulted in a nearly complete elimination of the metastases in a breast cancer model. This study is discussed below.

Keywords: IL-12; Listeria-Mage-b; STING ligand; c-di-GMP; metastatic breast cancer.